logo
Search orAI Icon𝛼SK
ENTITY

NanoViricides (NNVC US)

4
Analysis
Health Care • United States
NanoViricides, Inc. is a biopharmaceutical company. The Company researches treatments for viruses such as AIDS/HIV, Hepatitis C, influenza, and Asian bird flu.
more
bullish•NanoViricides
•08 Nov 2025 01:00•Issuer-paid

NNVC: Getting Set for Phase 2 Trial of

NanoViricides, Inc. (NNVC) is a clinical-stage company that is developing NV-387, a novel antiviral compound that will be initiating a clinical...

Logo
Share
bullish•NanoViricides
•07 Nov 2025 00:00•Issuer-paid

NNVC: Getting Set for Phase 2 Trial of

NanoViricides, Inc. (NNVC) is a clinical-stage company that is developing NV-387, a novel antiviral compound that will be initiating a clinical...

Logo
Share
bullish•NanoViricides
•18 Jul 2025 02:00•Issuer-paid

NanoViricides Inc -

Zacks Small-Cap Research Note for NanoViricides, Inc. (NNVC)

Logo
Share
bullish•NanoViricides
•14 Jul 2025 22:00•Issuer-paid

NanoViricides Inc -

Zacks Small-Cap Research Note for NanoViricides, Inc. (NNVC)

Logo
Share
No more insights

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.59.7

x